Download video

Assessing Risk in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: How to Approach Ch...

37 views

Medscape

4 months ago

Assessing Risk in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: How to Approach Ch...

Assessing Risk in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: How to Approach Ch...

Assessing Risk in Hormone Receptor-Positive\/HER2-Negative Early Breast Cancer: How to Approach Ch...
31:59
Assessing Risk in Hormone Receptor-Positive\/HER2-Negative Early Breast Cancer: How to Approach Ch...
by Medscape
New horizons in high-risk HR+ HER2- EBC: Risk stratification for early identification
40:56
New horizons in high-risk HR+ HER2- EBC: Risk stratification for early identification
by Touch Medical Media
Conceptualizing Guidelines to Manage Patients with HR–Positive, HER2-Negative Early Breast Cancer
30:49
Conceptualizing Guidelines to Manage Patients with HR–Positive, HER2-Negative Early Breast Cancer
by Medscape
Raising the Bar in HR+\/HER2- Early Breast Cancer: CDK4 and 6 Inhibitors
1:09:24
Raising the Bar in HR+\/HER2- Early Breast Cancer: CDK4 and 6 Inhibitors
by PeerView Oncology
Breaking Down Barriers to Treatment Adherence and Persistence in HR+\/HER2- Early Breast Cancer
55:30
Breaking Down Barriers to Treatment Adherence and Persistence in HR+\/HER2- Early Breast Cancer
by PeerView Oncology
“An Integrated Approach to Breast Cancer Risk Assessment Using MammoScreen and Epic in Primary Care”
1:03:34
“An Integrated Approach to Breast Cancer Risk Assessment Using MammoScreen and Epic in Primary Care”
by OHSU Informatics
Early Stage Breast Cancer | 2022 OneOncology Conference
22:47
Early Stage Breast Cancer | 2022 OneOncology Conference
by Total Health | Oncology
Step-Wise Approach for Breast Cancer Risk Assessment
3:32
Step-Wise Approach for Breast Cancer Risk Assessment
by Mayo Proceedings
Breast Cancer Risk Assessment - A Personalized Approach to Breast Health
24:27
Breast Cancer Risk Assessment - A Personalized Approach to Breast Health
by Charlotte Radiology
Assessment of short preoperative endocrine therapy in the ADAPT and ADAPTcycle trials
4:02
Assessment of short preoperative endocrine therapy in the ADAPT and ADAPTcycle trials
by VJOncology
Dr. Denduluri on Treatment Approaches in Early-Stage HR+\/HER2- Breast Cancer
1:51
Dr. Denduluri on Treatment Approaches in Early-Stage HR+\/HER2- Breast Cancer
by OncLive
Important considerations in the management of HR+, HER2-negative early breast cancer
2:05
Important considerations in the management of HR+, HER2-negative early breast cancer
by VJOncology